Onderneming Champions Oncology Inc OTC Bulletin Board
Aandelen
US15870P1093
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmacology Services
94,1
%
| 47 | 95,4 % | 51 | 94,1 % | +8,27% |
Other Translational Oncology Solutions
5,7
%
| 2 | 4,5 % | 3 | 5,7 % | +36,78% |
Personalized Oncology Services
0,2
%
| 0 | 0,1 % | 0 | 0,2 % | +136,73% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 49 | 100,0 % | 54 | 100,0 % | +9,69% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ronnie Morris
CEO | Chief Executive Officer | 58 | 26-10-10 |
Brady Davis
PSD | President | - | 17-10-23 |
Joel Ackerman
CHM | Chairman | 59 | 26-10-10 |
David Miller
DFI | Director of Finance/CFO | 55 | 01-06-13 |
Karin Heidemann
CTO | Chief Tech/Sci/R&D Officer | - | 01-09-19 |
Maria Mancini
COO | Chief Operating Officer | - | 01-03-15 |
Philip Breitfeld
BRD | Director/Board Member | 71 | 11-04-16 |
Rachel Bunting
IRO | Public Communications Contact | - | - |
Marianna Zipeto
PRN | Corporate Officer/Principal | - | 01-03-20 |
Ido Ben-Zvi
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Sidransky
FOU | Founder | 64 | 01-01-08 |
Scott Tobin
BRD | Director/Board Member | 53 | 27-06-11 |
Joel Ackerman
CHM | Chairman | 59 | 26-10-10 |
Daniel Mendelson
BRD | Director/Board Member | 60 | 01-03-13 |
Ronnie Morris
CEO | Chief Executive Officer | 58 | 26-10-10 |
Philip Breitfeld
BRD | Director/Board Member | 71 | 11-04-16 |
Robert Brainin
BRD | Director/Board Member | 53 | 08-02-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 13 714 099 | 10 119 930 ( 73,79 %) | 120 333 ( 0,8774 %) | 73,79 % |
Bedrijfsgegevens
Champions Oncology, Inc.
One University Plaza Suite 307
07601, Hackensack
+201 808 8400
http://www.championsoncology.comSector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
+40,37% | 54,04 mld. | |
+43,91% | 41,96 mld. | |
-1,34% | 41,92 mld. | |
-7,20% | 28,35 mld. | |
+12,70% | 26,35 mld. | |
-21,82% | 19 mld. | |
+7,01% | 13 mld. | |
+28,89% | 12,28 mld. | |
+25,53% | 12,19 mld. |
- Beurs
- Aandelen
- Koers CSBR
- Koers
- Onderneming Champions Oncology Inc